The PurpleLab^® Resource Center

The fact that healthcare organizations need to improve care outcomes is undeniably undisputed. To succeed, health plan leaders need to acknowledge that medical care is estimated to account for only 10% to 20% of the modifiable contributors to healthy outcomes for a population. The other 80% to 90% emanates from social determinants of health (SDOH),…

This blog is part four in a series exploring the use of real-world evidence to produce meaningful insights in clinical pharma.  Medical affairs is a department within pharmaceutical companies that focuses on communicating scientific and clinical information to healthcare providers. Pharmaceutical medical affairs teams are responsible for activities that bridge the gap between the development…

Amidst the backdrop of evolving privacy regulations and the phasing out of traditional digital identifiers, the video explores the essential strategies pharmaceutical advertisers must adopt to navigate these industry challenges and accurately assess the real-world outcomes they are achieving from their advertising. This is a video recording of a speaking session produced in partnership with…